Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1970 1
1974 1
1975 1
1977 1
1978 3
1979 1
1980 1
1982 2
1983 2
1984 1
1985 4
1986 2
1987 5
1988 9
1989 10
1990 12
1991 10
1992 10
1993 14
1994 12
1995 10
1996 15
1997 14
1998 14
1999 15
2000 18
2001 30
2002 17
2003 33
2004 24
2005 22
2006 29
2007 26
2008 23
2009 18
2010 18
2011 23
2012 26
2013 40
2014 22
2015 23
2016 24
2017 28
2018 46
2019 32
2020 37
2021 25
2022 32
2023 31
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

763 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: paraparesis-deafness
Page 1
Cerebral Palsy: An Overview.
Gulati S, Sondhi V. Gulati S, et al. Indian J Pediatr. 2018 Nov;85(11):1006-1016. doi: 10.1007/s12098-017-2475-1. Epub 2017 Nov 20. Indian J Pediatr. 2018. PMID: 29152685 Review.
Cerebral palsy (CP) is a neurodevelopmental disorder characterized by abnormalities of muscle tone, movement and motor skills, and is attributed to injury to the developing brain. The clinical features of this entity evolve over time and the specific CP syndrome may …
Cerebral palsy (CP) is a neurodevelopmental disorder characterized by abnormalities of muscle tone, movement and motor skills, and is …
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J. Whiting PF, et al. JAMA. 2015 Jun 23-30;313(24):2456-73. doi: 10.1001/jama.2015.6358. JAMA. 2015. PMID: 26103030 Review.
STUDY SELECTION: Randomized clinical trials of cannabinoids for the following indications: nausea and vomiting due to chemotherapy, appetite stimulation in HIV/AIDS, chronic pain, spasticity due to multiple sclerosis or paraplegia, depression, anxiety disorder, sleep disor …
STUDY SELECTION: Randomized clinical trials of cannabinoids for the following indications: nausea and vomiting due to chemotherapy, appetite …
A Diagnostic Approach to Spastic ataxia Syndromes.
Pedroso JL, Vale TC, França Junior MC, Kauffman MA, Teive H, Barsottini OGP, Munhoz RP. Pedroso JL, et al. Cerebellum. 2022 Dec;21(6):1073-1084. doi: 10.1007/s12311-021-01345-5. Epub 2021 Nov 15. Cerebellum. 2022. PMID: 34782953 Review.
Spastic ataxia is characterized by the combination of cerebellar ataxia with spasticity and other pyramidal features. ...A diagnostic approach for spastic ataxias is then proposed....
Spastic ataxia is characterized by the combination of cerebellar ataxia with spasticity and other pyramidal features. ...A dia …
Pain after stroke: A review.
Delpont B, Blanc C, Osseby GV, Hervieu-Bègue M, Giroud M, Béjot Y. Delpont B, et al. Rev Neurol (Paris). 2018 Dec;174(10):671-674. doi: 10.1016/j.neurol.2017.11.011. Epub 2018 Jul 24. Rev Neurol (Paris). 2018. PMID: 30054011 Review.
To provide tools for practitioners, this report describes the most common PAS syndromes, including central post-stroke pain, spasticity and contractures, shoulder pain and complex regional pain syndromes, as well as headache and chondrocalcinosis, along with …
To provide tools for practitioners, this report describes the most common PAS syndromes, including central post-stroke pain, spast …
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
The role of the endocannabinoid system in addictions has also been examined, and cannabinoids have been postulated as alternative and co-adjuvant treatments in some abuse syndromes, mainly in ethanol and opioid abuses. The expression of the endocannabinoid system in the ey …
The role of the endocannabinoid system in addictions has also been examined, and cannabinoids have been postulated as alternative and co-adj …
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L. Breijyeh Z, et al. Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117. Toxins (Basel). 2021. PMID: 33562446 Free PMC article. Review.
Some cannabinoids are clinically applied for treating chronic pain, particularly cancer and multiple sclerosis-associated pain, for appetite stimulation and anti-emesis in HIV/AIDS and cancer patients, and for spasticity treatment in multiple sclerosis and epilepsy patient …
Some cannabinoids are clinically applied for treating chronic pain, particularly cancer and multiple sclerosis-associated pain, for appetite …
Treatment of spasticity.
Marsden J, Stevenson V, Jarrett L. Marsden J, et al. Handb Clin Neurol. 2023;196:497-521. doi: 10.1016/B978-0-323-98817-9.00010-7. Handb Clin Neurol. 2023. PMID: 37620087 Review.
The choice of management strategies for an individual will vary depending on the severity of spasticity, the distribution of spasticity (i.e., whether it affects multiple muscle groups or is more prominent in one or two groups), the type of lesion, and the po …
The choice of management strategies for an individual will vary depending on the severity of spasticity, the distribution of spast …
Spasticity: pathophysiology, evaluation and management.
Kheder A, Nair KP. Kheder A, et al. Pract Neurol. 2012 Oct;12(5):289-98. doi: 10.1136/practneurol-2011-000155. Pract Neurol. 2012. PMID: 22976059 Review.
It is part of the upper motor neurone syndrome manifesting as increased tone, clonus, spasms, spastic dystonia and co-contractions. The impact of spasticity varies from it being a subtle neurological sign to severe spasticity causing pain and contractu …
It is part of the upper motor neurone syndrome manifesting as increased tone, clonus, spasms, spastic dystonia and co-contract …
The glucose transporter type 1 (Glut1) syndromes.
Koch H, Weber YG. Koch H, et al. Epilepsy Behav. 2019 Feb;91:90-93. doi: 10.1016/j.yebeh.2018.06.010. Epub 2018 Jul 31. Epilepsy Behav. 2019. PMID: 30076047 Review.
In the early nineties, the first genetic defect of Glut1 was described and known as the Glut1 deficiency syndrome (Glut1-DS). It is characterized by early infantile seizures, developmental delay, microcephaly, and ataxia. ...The present article summarizes the clinical feat …
In the early nineties, the first genetic defect of Glut1 was described and known as the Glut1 deficiency syndrome (Glut1-DS). It is c …
Genetic mimics of cerebral palsy.
Pearson TS, Pons R, Ghaoui R, Sue CM. Pearson TS, et al. Mov Disord. 2019 May;34(5):625-636. doi: 10.1002/mds.27655. Epub 2019 Mar 26. Mov Disord. 2019. PMID: 30913345 Review.
Cerebral palsy describes a heterogeneous group of neurodevelopmental disorders characterized by onset in infancy or early childhood of motor symptoms (including hypotonia, spasticity, dystonia, and chorea), often accompanied by developmental delay. The primary etiology of …
Cerebral palsy describes a heterogeneous group of neurodevelopmental disorders characterized by onset in infancy or early childhood of motor …
763 results